The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| ZSTK | -71.12% | N/A | N/A | -100% |
| S&P | +21.6% | +71.83% | +11.43% | +63% |
Flora Growth Corp. engages in the production of organic cannabis and pharmaceutical-grade medical products. It operates through the following segments: Cultivation, Processing, and Supplying of Natural, Medicinal-Grade Cannabis Oil and High Quality Cannabis; Over-the-Counter Medical Products and Medical Cannabis Products; Wellbeing Products; and Food and Beverage Products. The company was founded on March 13, 2019 and is headquartered in Toronto, Canada.
It's all about a momentous event that happened recently in a small Central American country.
The cannabis stock traded nearly $1 a share higher before falling back down to near where it started the day.
| Q4 2025 | YOY Change | |
|---|---|---|
| Revenue | $9.35M | -29.8% |
| Gross Profit | -$2,613.00K | -6.4% |
| Gross Margin | -27.94% | -9.5% |
| Market Cap | $4.68M | -75.5% |
| Market Cap / Employee | $222.62K | 0.0% |
| Employees | 21 | -72.4% |
| Net Income | -$109,903.00K | -1708.8% |
| EBITDA | -$4,423.00K | 22.9% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q4 2025 | YOY Change | |
|---|---|---|
| Net Cash | $5.62M | -7.1% |
| Accounts Receivable | $370.00K | -78.5% |
| Inventory | 1.9 | -67.1% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $51.05M | 2415.8% |
| Short Term Debt | $2.89M | 0.5% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -149.17% | -85.4% |
| Return On Invested Capital | -215.94% | -102.9% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$2,701.94K | -116.0% |
| Operating Free Cash Flow | -$3,093.52K | -146.9% |
| Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 2.47 | 3.25 | 2.48 | 0.07 | -98.38% |
| Price to Sales | 0.22 | 0.24 | 0.26 | 0.14 | -39.46% |
| Price to Tangible Book Value | -1804.92 | -179.30 | -2.95 | 0.07 | -100.02% |
| Enterprise Value to EBITDA | -9.50 | -7.04 | -1.13 | -12.39 | 449.11% |
| Return on Equity | -336.7% | -230.7% | -37.4% | -310.9% | 6.67% |
| Total Debt | $7.30M | $7.77M | $3.25M | $53.93M | 1000.63% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
